퀴닌 및 그 염류
Listed by the Korean MFDS as a cosmetic ingredient requiring conditions of use.
监管决定及完整条件
- 状态
- Restricted
- 法律地位
- Binding rule
- 监管摘要
- Listed by the Korean MFDS as a cosmetic ingredient requiring conditions of use.
- 条件与限制
?샴푸에 퀴닌염으로서 0.5% ?헤어로션에 퀴닌염로서 0.2% · 기타 제품에는 사용금지 · 퀴닌
物质身份
- 官方来源名称
- 퀴닌 및 그 염류
- CAS
- 130-95-0
- EC
- 205-003-2
- 身份映射
- cas_number
- 关联成分
- QUININE
关联的 CosIng 身份数据
名称和别名
CosIng 描述: Cinchonan-9-ol, 6'-methoxy-, (8.alpha., 9R)-
欧盟清单限制备注: III/21
已记录的化妆品功能: DENATURANT, FRAGRANCE, HAIR CONDITIONING
功能页面:DENATURANT, FRAGRANCE, HAIR CONDITIONING
查看完整的成分档案该身份的跨市场概览
本站目前已有的精确关联记录。某市场缺失表示没有已导入的精确匹配,并不表示准许使用该物质。
European Union
1 条关联记录 · 1 条含特定条件
打开支持记录Great Britain
1 条关联记录 · 1 条含特定条件
打开支持记录New Zealand
1 条关联记录 · 1 条含特定条件
打开支持记录ASEAN
1 条关联记录 · 1 条含特定条件
打开支持记录South Korea
当前记录1 条关联记录 · 1 条含特定条件
打开支持记录Australia
1 条关联记录 · 1 条含特定条件
打开支持记录India
1 条关联记录 · 1 条含特定条件
打开支持记录Saudi Arabia
1 条关联记录
打开支持记录
CAS 130-95-0 的已核实化学信息
Quinine
Quinine is a cinchona alkaloid that is cinchonidine in which the hydrogen at the 6-position of the quinoline ring is substituted by methoxy. It has a role as a non-narcotic analgesic, an antimalarial and a muscle relaxant. It is a conjugate base of a quinine(1+). It derives from a hydride of an (8S)-cinchonan. — ChEBI
- IUPAC 名称
- (R)-[(2S,4S,5R)-5-ethenyl-1-azabicyclo[2.2.2]octan-2-yl]-(6-methoxyquinolin-4-yl)methanol
- 分子式
- C20H24N2O2
- 分子量
- 324.4 g/mol
- 精确质量
- 324.183778013 Da
- 单同位素质量
- 324.183778013 Da
- XLogP3
- 2.9
- 拓扑极性表面积
- 45.6 Ų
- 分子复杂度
- 457.0
- 形式电荷
- 0
- 氢键供体
- 1
- 氢键受体
- 4
- 可旋转键
- 4
- 重原子
- 24
- 共价单元
- 1
向 PubChem 报告的名称和同义词
另有 16 个已报告名称
外部数据库标识符
高级结构统计
- 已定义的原子立体中心
- 4
- 未定义的原子立体中心
- 0
- 已定义的键立体中心
- 0
- 未定义的键立体中心
- 0
- 三维药效团特征
- 9
- 三维环
- 3
- 三维疏水基团
- 1
- 三维受体特征
- 3
- 三维供体特征
- 1
- 三维阴离子中心
- 0
- 三维阳离子中心
- 1
- 三维构象异构体
- 7
- 有效三维可旋转键
- 5.2
机器可读的结构标识符
- SMILES
COC1=CC2=C(C=CN=C2C=C1)[C@H]([C@@H]3C[C@@H]4CCN3C[C@@H]4C=C)O- InChI
InChI=1S/C20H24N2O2/c1-3-13-12-22-9-7-14(13)10-19(22)20(23)16-6-8-21-18-5-4-15(24-2)11-17(16)18/h3-6,8,11,13-14,19-20,23H,1,7,9-10,12H2,2H3/t13-,14-,19-,20+/m0/s1- InChIKey
LOUPRKONTZGTKE-WZBLMQSHSA-N
来自其他科学数据库的证据
NIH PubChem PUG-View
Attributed physical-property, hazard, environmental and use annotations.
- Color/Form: Triboluminescent, orthorhombic needles from absolute alcohol 来源: Hazardous Substances Data Bank (HSDB)
- Color/Form: Bulky, white, amorphous powder or crystalline alkaloid 来源: Hazardous Substances Data Bank (HSDB)
- Color/Form: CRYSTALS TURN BROWN ON EXPOSURE TO AIR 来源: Hazardous Substances Data Bank (HSDB)
- Basic pKa: 8.56 来源: ChEMBL
- Basic pKa: 8.55 来源: ChEMBL
- Dissociation Constants: pK1 (18 °C) = 5.07; pK2 = 9.7 来源: Hazardous Substances Data Bank (HSDB)
- LogP: 3.44 来源: DrugBank
- LogP: log Kow = 3.44 来源: Hazardous Substances Data Bank (HSDB)
- LogP: 2.6 来源: Human Metabolome Database (HMDB)
- Melting Point: 57 °C 来源: DrugBank
- Melting Point: 177 °C (some decomposition) 来源: Hazardous Substances Data Bank (HSDB)
- Melting Point: Microcrystalline powder; mp: 57 °C; efflorescent; loses one water molecule in air, two water molecules over sulfuric acid; anhydrous at 125 °C /Quinine trihydrate/ 来源: Hazardous Substances Data Bank (HSDB)
- Melting Point: 57 °C 来源: Human Metabolome Database (HMDB)
- Odor: ODORLESS 来源: Hazardous Substances Data Bank (HSDB)
- Physical Description: Solid 来源: Human Metabolome Database (HMDB)
- Refractive Index: INDEX OF REFRACTION: 1.625 来源: Hazardous Substances Data Bank (HSDB)
- Solubility: 500 mg/L (at 15 °C) 来源: DrugBank
- Solubility: In water, 500 mg/L at 15 °C 来源: Hazardous Substances Data Bank (HSDB)
- Solubility: 1 g dissolves in: 1900 mL water, 760 mL boiling water 来源: Hazardous Substances Data Bank (HSDB)
- Solubility: 1 g dissolves in: 80 mL benzene (18 mL at 50 °C), 1.2 mL chloroform, 250 mL dry ether, 20 mL glycerol, 0.8 mL alcohol, 1900 mL of 10% ammonia water; almost insoluble in petroleum ether 来源: Hazardous Substances Data Bank (HSDB)
- Solubility: Soluble in ether, chloroform, carbon disulfide, glycerol, alkalies, and acids (with formation of salts) 来源: Hazardous Substances Data Bank (HSDB)
- Solubility: Sol in pyrimidine 来源: Hazardous Substances Data Bank (HSDB)
- Solubility: 3.34e-01 g/L 来源: Human Metabolome Database (HMDB)
- pH: pH of saturated aqueous solution = 8.8 来源: Hazardous Substances Data Bank (HSDB)
- Carcinogen Classification: No indication of carcinogenicity to humans (not listed by IARC). 来源: Toxin and Toxin Target Database (T3DB)
- Exposure Routes: Oral 来源: Toxin and Toxin Target Database (T3DB)
- Signal: Danger 来源: European Chemicals Agency (ECHA)
- GHS Hazard Statements: H302 (22.9%): Harmful if swallowed [Warning Acute toxicity, oral]; H315 (28.4%): Causes skin irritation [Warning Skin corrosion/irritation]; H317 (99.5%): May cause an allergic skin reaction [Warning Sensitization, Skin]; H319 (28.4%): Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H334 (83.1%): May cause allergy or asthma symptoms or breathing difficulties if inhaled [Danger Sensitization, respiratory] 来源: European Chemicals Agency (ECHA)
- Precautionary Statement Codes: P233, P260, P261, P264, P264+P265, P270, P271, P272, P280, P284, P301+P317, P302+P352, P304+P340, P305+P351+P338, P321, P330, P332+P317, P333+P317, P337+P317, P342+P316, P362+P364, P403, and P501 (click each P-code to see the statement) 来源: European Chemicals Agency (ECHA)
- ECHA C&L Notifications Summary: Aggregated GHS information provided per 201 reports by companies from 10 notifications to the ECHA C&L Inventory. Each notification may be associated with multiple companies.; Information may vary between notifications depending on impurities, additives, and other factors. The percentage value in parenthesis indicates the notified classification ratio from companies that provide hazard codes. Only hazard codes with percentage values above 10% are shown. For more detailed information, please visit ECHA C&L website. 来源: European Chemicals Agency (ECHA)
- Signal: Warning 来源: Hazardous Chemical Information System (HCIS), Safe Work Australia
- GHS Hazard Statements: H302: Harmful if swallowed [Warning Acute toxicity, oral]; H317: May cause an allergic skin reaction [Warning Sensitization, Skin] 来源: Hazardous Chemical Information System (HCIS), Safe Work Australia
- Precautionary Statement Codes: P261, P264, P270, P272, P280, P301+P317, P302+P352, P321, P330, P333+P317, P362+P364, and P501 (click each P-code to see the statement) 来源: Hazardous Chemical Information System (HCIS), Safe Work Australia
- Signal: Danger 来源: Hazardous Substances Data Bank (HSDB)
- GHS Hazard Statements: H315: Causes skin irritation [Warning Skin corrosion/irritation]; H317: May cause an allergic skin reaction [Warning Sensitization, Skin]; H319: Causes serious eye irritation [Warning Serious eye damage/eye irritation]; H334: May cause allergy or asthma symptoms or breathing difficulties if inhaled [Danger Sensitization, respiratory] 来源: Hazardous Substances Data Bank (HSDB)
- Precautionary Statement Codes: P233, P260, P261, P264, P264+P265, P271, P272, P280, P284, P302+P352, P304+P340, P305+P351+P338, P321, P332+P317, P333+P317, P337+P317, P342+P316, P362+P364, P403, and P501 (click each P-code to see the statement) 来源: Hazardous Substances Data Bank (HSDB)
- Health Effects: It is usual for quinine in therapeutic doses to cause cinchonism; in rare cases, it may even cause death (usually by pulmonary edema). Quinine can worsen hemoglobinuria, myasthenia gravis and optic neuritis. It can cause paralysis if accidentally injected into a nerve, and is extremely toxic in overdose[Wikipedia] 来源: Toxin and Toxin Target Database (T3DB)
- Toxicity Summary: IDENTIFICATION AND USE: Quinine is a bulky, white, amorphous powder or crystalline alkaloid, used as medication: non-narcotic analgesics; antimalarial; central muscle relaxants. It is also used as flavor in carbonated beverages. HUMAN EXPOSURE AND TOXICITY: Serious hypersensitivity reactions, including anaphylactic shock, anaphylactoid reactions, urticaria, serious skin rashes, angioedema, facial edema, bronchospasm, and pruritus, have been reported with quinine. In addition, thrombocytopenia, hemolytic uremic syndrome/thrombotic thrombocytopenic purpura (HUS/TTP), immune thrombocytopenic purpura, blackwater fever, disseminated intravascular coagulation, leukopenia, neutropenia, granulomatous hepatitis, and acute interstitial nephritis have been reported and may also be due to hypersensitivity reactions to the drug. Potentially fatal cardiac arrhythmias, including torsades de pointes and ventricular fibrillation, have been reported rarely during quinine therapy. At least 1 case of fatal ventricular arrhythmia has been reported in a geriatric patient with preexisting prolonged QT interval treated with IV quinine sulfate for Plasmodium falciparum malaria. Visual impairment can range 来源: Hazardous Substances Data Bank (HSDB)
- Toxicity Summary: The theorized mechanism of action for quinine and related anti-malarial drugs is that these drugs are toxic to the malaria parasite. Specifically, the drugs interfere with the parasite's ability to break down and digest hemoglobin. Consequently, the parasite starves and/or builds up toxic levels of partially degraded hemoglobin in itself. 来源: Toxin and Toxin Target Database (T3DB)
- Uses: Medicine (antimalarial) as the alkaloid or as numerous salts and derivatives; flavoring in carbonated beverages 来源: Hazardous Substances Data Bank (HSDB)
- Uses: Flavor in carbonated beverages. 来源: Hazardous Substances Data Bank (HSDB)
- Uses: MEDICATION 来源: Hazardous Substances Data Bank (HSDB)
- Uses: MEDICATION (VET) 来源: Hazardous Substances Data Bank (HSDB)
- Uses: For more Uses (Complete) data for QUININE (8 total), please visit the HSDB record page. 来源: Hazardous Substances Data Bank (HSDB)
- Uses: Use (kg; approx.) in Germany (2009): >5000; Use (kg) in USA (2002): 56800; Consumption (g per capita; approx.) in Germany (2009): 0.0611; Consumption (g per capita) in the USA (2002): 0.201; Calculated removal (%): 41.8 来源: NORMAN Suspect List Exchange
- Uses: For the treatment of malaria and leg cramps. Used as an antipyretic (fever-reducing), antimalarial, analgesic (painkilling), and anti-inflammatory. It is also used as a flavor component of tonic water and bitter lemon. 来源: Toxin and Toxin Target Database (T3DB)
映射方: Existing checksum-valid CAS to unique PubChem CID match. 检索时间: 2026-08-31. 打开来源记录
科学分类和危害注释仅提供背景信息,不能取代上方所示针对具体市场的监管决定。
其他来源的覆盖范围和匹配状态
| 来源 | 结果 | 已检查 |
|---|---|---|
| NIH PubChem PUG-View | 精确匹配 | 2026-08-31 |
已记录的无匹配结果是该来源已被检查的有效证据;这并不表示该物质在别处不存在。
于 2026-08-31 通过校验和有效的 CAS 匹配从美国国立卫生研究院 (NIH) PubChem 检索。化学性质不能取代本页的监管决定。
官方来源与出处
- 已登记来源
- South Korea MFDS cosmetic ingredient data
- 来源参考
- 화장품 안전기준 등에 관한 규정, 별표 2, record 2-394
- 来源记录 ID
2-394- 来源版本
- 2026-19
- 来源语言
- Korean
- 翻译状态
- No English translation
- 生效日期
- 2026-03-18
- 来源更新
- 2026-03-18
- 快照检查时间
- 2026-08-30 04:33 UTC
- 验证方法
- MFDS JSON appendices 1–2 parse; 1077 prohibited, 243 restricted
- SHA-256
056de35b843a5e31f709073f9e79d5e6e18f7c9164eb537bb099b185a37ef7d8
已登记的数据集备注
- 数据集覆盖范围
- Ingredient identity and separate restriction/regulation data endpoints
- 权威性说明
- Korean source is canonical; English materials alone are not complete enough for certification
本记录在市场数据集中的位置
South Korea 市场背景
Complete current appendix dataset
覆盖版本: MFDS Notice 2026-19, effective 18 March 2026
All rows in official Appendix 1 (prohibited) and Appendix 2 (restricted) of the Safety Standards for Cosmetics.
核实清单
- Match the Korean canonical substance name and identifiers.
- Review all Appendix 1 and 2 matches and conditions.
- Check functional-cosmetic and positive-list requirements where applicable.
- Confirm current MFDS notice, responsible seller and label obligations.
官方市场来源
- South Korea MFDS cosmetic ingredient dataKorean source is canonical; English materials alone are not complete enough for certification
核实工作流程与记录完整性
在将此结果用于合规决定之前
- 确认“퀴닌 및 그 염류”及每个 CAS/EC 标识符所指的物料与您的供应商规格一致。
- Match the Korean canonical substance name and identifiers.
- Review all Appendix 1 and 2 matches and conditions.
- Check functional-cosmetic and positive-list requirements where applicable.
- Confirm current MFDS notice, responsible seller and label obligations.
- 记录来源版本,并在生产、备案或上市之前重新核查监管机构。
本记录中的可用字段
- 官方物质名称可用
- CAS可用
- EC可用
- 单独的条件文本可用
- 生效日期可用
- 快照哈希与方法可用
本页回答的问题
稳定引用
퀴닌 및 그 염류. 화장품 안전기준 등에 관한 규정, 별표 2, record 2-394. South Korea. Source version 2026-19. CosIng Checker regulatory record: https://cosingchecker.com/zh-hans/regulations/kr/records/2121/
请将监管机构作为法律依据来引用。本页是结构化的证据索引和核实辅助工具,不能替代官方文本或专业法律评估。
South Korea 的解读与局限
This substance is not unrestricted: cosmetic use is subject to the conditions in the cited official record.
Check product type, body area, concentration, purity and warning requirements before deciding whether a formulation is compliant.
如何解读法律地位
The cited row forms part of a binding rule or legally incorporated list for this market.
本页证据
- 记录结果:Restricted
- 法律地位:Binding rule
- 来源版本:2026-19
- 生效日期:2026-03-18
它不能证明什么
Korean source wording is canonical and other positive lists/notices may still apply to the formulation.
进一步的权威物质研究
这些来源均不能推翻上述市场决定。
Cosmetic Ingredient Review safety assessments
Expert Panel conclusions, assessed ingredient groups, use conditions, dates and report documents
Independent expert review considered by FDA; not a government approval or binding market rule
在来源处研究此身份FDA Global Substance Registration System
UNII identifiers, preferred names, substance types, codes and public substance relationships
Identity registry only; UNII availability does not imply FDA review or approval
在来源处研究此身份ILO/WHO International Chemical Safety Cards
Hazards, symptoms, first aid, storage, incompatibilities and physical properties for covered chemicals
International occupational chemical-safety reference; not cosmetic-use approval
在来源处研究此身份Japan NITE-CHRIP
Chemical identity, Japanese and foreign legal lists, GHS hazards and exposure-related information
Chemical-management evidence; cosmetic status remains governed by the applicable MHLW standard and market rules
在来源处研究此身份NIOSH Pocket Guide to Chemical Hazards
REL, PEL, IDLH, properties, exposure routes, symptoms, target organs, first aid and measurement methods for covered workplace chemicals
US occupational-health guidance and limits; not a cosmetic ingredient decision
在来源处研究此身份OECD eChemPortal
Gateway to authority-owned physical-property, fate, ecotoxicity, toxicity, exposure and GHS records
Discovery gateway; each linked authority remains responsible for its data
在来源处研究此身份US EPA CompTox CTX APIs
导入需要 API 密钥DTXSID identity, experimental and predicted properties, toxicity, bioactivity, exposure and environmental data
Scientific and computational evidence; predictions must remain labelled and do not determine cosmetic legality
在来源处研究此身份